XML 27 R19.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under its Plans is as follows (in thousands, except share, per share data and years):

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2023

 

 

7,989,192

 

 

$

12.08

 

 

 

7.8

 

 

$

16,733

 

Granted

 

 

2,176,966

 

 

$

12.49

 

 

 

 

 

 

 

Exercised

 

 

(441,368

)

 

$

9.98

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(69,326

)

 

$

17.00

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

9,655,464

 

 

$

12.23

 

 

 

7.8

 

 

$

286,883

 

Vested and expected to vest at June 30, 2024

 

 

9,655,464

 

 

$

12.23

 

 

 

7.8

 

 

$

286,883

 

Exercisable at June 30, 2024

 

 

5,637,906

 

 

$

10.78

 

 

 

7.0

 

 

$

175,375

 

Summary of Fair Value of Stock Option Grants

The assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants under the Plans were as follows:

 

 

 

Six Months Ended June 30,

 

 

2024

 

2023

Risk-free interest rate

 

3.8% – 4.6%

 

3.5% – 4.2%

Expected volatility

 

83% – 91%

 

83% – 87%

Expected term (in years)

 

5.3 – 6.1

 

5.3 – 6.1

Expected dividend yield

 

 

Summary of Stock-Based Compensation Expense

Stock-based compensation expense has been reported in the condensed statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
 June 30,

 

 

Six Months Ended
 June 30,

 

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Research and development

 

$

2,324

 

 

$

2,449

 

 

$

4,508

 

 

$

4,807

 

General and administrative

 

 

3,433

 

 

 

3,052

 

 

 

6,874

 

 

 

6,167

 

Total

 

$

5,757

 

 

$

5,501

 

 

$

11,382

 

 

$

10,974

 

Summary of Unvested Shares and Unvested Stock Liabilities

A summary of the Company’s unvested shares and unvested stock liabilities is as follows (in thousands, except share data):

 

 

 

Number of
Unvested
Shares

 

 

Weighted-Average Grant Date Fair Value

 

 

Unvested
Stock Liabilities

 

Balance at December 31, 2023

 

 

10,319

 

 

$

1.57

 

 

$

20

 

Vested shares

 

 

(8,036

)

 

$

1.01

 

 

 

(10

)

Balance at June 30, 2024

 

 

2,283

 

 

$

3.53

 

 

$

10

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following:

 

 

 

June 30,
2024

 

 

December 31,
2023

 

Common stock options outstanding

 

 

9,655,464

 

 

 

7,989,192

 

RSUs outstanding

 

 

17,500

 

 

 

 

Shares available for issuance under the Plans

 

 

5,386,938

 

 

 

5,198,941

 

Shares available for issuance under the ESPP

 

 

1,542,307

 

 

 

1,142,750

 

Pre-funded common stock warrants outstanding

 

 

2,438,709

 

 

 

503,226

 

Total

 

 

19,040,918

 

 

 

14,834,109

 

Two Thousand Twenty One Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Restricted Stock Unit ("RSU") Activity

A summary of the Company’s restricted stock unit (“RSU”) activity under the 2021 Plan is as follows:

 

 

 

Number of
Restricted Stock Units

 

 

Weighted-
Average Grant Date Fair Value per Share

 

Outstanding at December 31, 2023

 

 

 

 

$

 

Granted

 

 

17,500

 

 

$

39.80

 

Vested

 

 

 

 

$

 

Forfeited or cancelled

 

 

 

 

$

 

Outstanding at June 30, 2024

 

 

17,500

 

 

$

39.80